AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
E112: Is Davos a grift? Plus: globalist mishaps, debt ceilings, TikTok's endgame & more
All-In with Chamath, Jason, Sacks & Friedberg
The Value of Acquisition in ML&A
When I was at Monsanto, we had all this IP licensing deals and new products would come to market. And it was never cost plus or simple pricing. It was always about value capture. And the same is true in biotech and pharma. The best performing company in pharma is a company called Royalty Pharma. That's a $22.5 billion company with 90% EBITDA margins.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode